Dissemin is shutting down on January 1st, 2025

Published in

Wiley, Journal of Polymer Science Part A: Polymer Chemistry, 12(46), p. 4130-4139, 2008

DOI: 10.1002/pola.22759

Links

Tools

Export citation

Search in Google Scholar

Synthesis and hydrolytic stability of poly(oxyethylene-H-phosphonate)s

Journal article published in 2008 by Ivan Gitsov ORCID, Frederick E. Johnson
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Poly(oxyethylene-H-phosphonate)s (POE-H-Ps), with different poly(oxyethylene) segment lengths, were synthesized via conventional two-stage polycondensation reaction of dimethyl-H-phosphonate and poly(ethylene glycols) (PEGs), with nominal molecular weights of 400, 600, and 1000 Da. The changes in the composition of the reaction mixtures during the polycondensation process were followed by size-exclusion chromatography (SEC) and NMR. It was found that the three PEG fragments yield reproducibly POE-H-Ps with the following molecular weights: ∼3000 Da (PEG-400), ∼6000 Da (PEG-600), and ∼10,000 Da (PEG-1000) as measured by SEC, NMR, and VPO. The hydrolytic behavior of POE-H-Ps upon storage and in aqueous media with pH 3, 7.4, and 8 was studied for the first time by a combination of NMR and SEC. It was found that the long-term stability of the polymers in dry state depends on the length of the PEG fragments and decreased in the following order: POE-H-P(PEG-1000) > POE-H-P(PEG-600) > POE-H-P(PEG-400). The hydrolytic transformation of the polymers in aqueous media is affected mostly by the pH of the solution. The degradation products are PEG fragments containing phosphonate end groups—an important prerequisite for the usage of the POE-H-Ps as nontoxic drug delivery vehicles and in vivo precursors for PEGylated prodrugs.